The announcement was made at the European Society of Cardiology Congress in Stockholm and demonstrates the organisations’ shared commitment to helping the global population achieve a longer and better life through the prevention and control of heart disease and stroke.
Through a partnership, Bayer HealthCare will aid the World Heart Federation in its mission to educate the public and Healthcare professionals of the risks of CVD, to help implement the Principles for National and Regional Guidelines on Cardiovascular Disease Prevention and in initiatives aimed at primary and secondary prevention.
Professor Valentin Fuster, President, World Heart Federation, said: “Our corporate partnership with Bayer HealthCare will help us to further develop our public education initiatives and to encourage the world's population to adopt a healthy lifestyle to reduce their risk of cardiovascular disease.”
He added: “For example, by taking more physical exercise, eating healthily, controlling weight and through smoke-free living.”
In addition to lifestyle changes, using medical therapies such as those which inhibit platelet aggregation, control high blood pressure, lower abnormal cholesterol and treat diabetes can reduce the risk of cardiovascular disease.
For more information, visit www.worldheart.org
